Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

關於 Lite Strategy

成立時間2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
社群
Twitter
Website
標簽
Publicly listed company
Crypto Stocks

熱度值變化趨勢

投融資詳情

Post-IPO(2025-07-21)
金額$31.46億
估值--